Dandelion root
Taraxaci officinalis radix
Taraxacum officinale F.H. Wigg.
HOS-216027hmpc:taraxaci-officinalis-radix-0
Botanische Abbildung
A Western Honey Bee ( Apis mellifera ) on dandelion in the protected landscape area Freisinger Moos und Echinger Gfild.
Artbezogene Illustration. Sie zeigt nicht automatisch die im Profil genannte Arzneidroge oder Zubereitung und dient nicht zur sicheren Bestimmung einer Giftpflanze.
Flocci Nivis · CC BY 4.0 · Bildquelle ↗
Bildzuordnung & Herkunft
- Originalangabe im Profil
- Taraxacum officinale F.H. Wigg.
- Taxonkennung
- Q131219 · Quellenrevision 2547654044
- Namenszuordnung
- Taraxacum officinale · Q131219 · Quellenrevision 2547654044
- Beleg der Bildzuordnung
- Wikimedia Commons: stellt dar (P180) · Quellenrevision 1180416561
Aussage:
M159831459$8E83DF97-DA03-4822-A0BD-CAEF45A8D2C0 - Bearbeitung
- auf maximal 1024 Pixel verkleinert, EXIF-Orientierung angewandt und als JPEG gespeichert; kein inhaltlicher Zuschnitt.
- Bildquelle abgerufen
- 26.10.2026
Bilddatei SHA-256: cfcb5fc87de1054b7f8f2101ac2012fd82246f61d44999a18fcdcb5682bb4ce0
- Themengebiete laut EMA
- Loss of appetite;Urinary tract and genital disorders;Gastrointestinal disorders
- Ergebnis der Bewertung laut EMA
- European Union herbal monograph
- Kombination laut EMA
- Nein
Pflanzen–Arzneimittel-Beziehungen 0 belegte Zuordnungen
Für diesen Quellenstand wurden noch keine eindeutigen Wirkstoffzuordnungen mit belegter Aussage übernommen.
Keine oder wenige Zuordnungen bedeuten nicht, dass keine Wechselwirkungen bestehen. Nicht eindeutig zuordenbare Aussagen bleiben im Originalabschnitt nachlesbar; verneinte Befunde gelten nur für die beschriebenen Bedingungen.
Sicherheit aus der Monographie Originalabschnitte
Englische Originalabschnitte mit unveränderten Spalten für etablierte und traditionelle Anwendung. Aussagen gelten für die im Dokument genannten Zubereitungen und Anwendungsarten. Aus ihnen werden hier keine Interaktionspaare oder Schweregrade abgeleitet.
Final European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix ↗
PDF abgerufen: 27.10.2026 · 8 Seiten · automatisch ausgelesen
Zubereitungs- und Anwendungskontext · Originaltext
Originalkontext vor Abschnitt 4.3, einschließlich der Angaben zu Zubereitungen und Anwendung. Buchstaben und Nummern der Zubereitungen werden in den Sicherheitsabschnitten wieder aufgegriffen.
1. Name of the medicinal product
To be specified for the individual finished product.
2. Qualitative and quantitative composition 2, 3
Well-established use Traditional use
With regard to the registration application of
Article 16d(1) of Directive 2001/83/EC.
Taraxacum officinale F.H. Wigg., radix
(dandelion root).
i) Herbal substance
Not applicable
ii) Herbal preparations
a) Comminuted dried root
b) Expressed juice (DER 1:1) from fresh root
subjected to a steam of ethanol
c) Juice from fresh root
d) Liquid extract (DER 1:1), extraction solvent
ethanol 30% V/V
e) Tincture (ratio of herbal substance to
extraction solvent 1:5), extraction solvent
ethanol 45% V/V
3. Pharmaceutical form
Well-established use Traditional use
Comminuted herbal substance as herbal tea for
oral use.
Herbal preparations in liquid dosage form for
oral use.
The pharmaceutical form should be described by
the European Pharmacopoeia full standard term.
2
The declaration of the active substance(s) for an individual finished product should be in accordance with relevant
herbal quality guidance.
3
The material complies with the Ph. Eur. monograph (ref.: 1852).
European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix
EMA/HMPC/475726/2020 Page 3/8
4. Clinical particulars
4.1. Therapeutic indications
Well-established use Traditional use
Indication 1)
Traditional herbal medicinal product used for the
relief of symptoms related to mild digestive
disorders (such as feeling of abdominal fullness,
flatulence, and slow digestion).
Indication 2)
Traditional herbal medicinal product for
temporary loss of appetite.
Indication 3)
Traditional herbal medicinal product to increase
the amount of urine to achieve flushing of the
urinary tract as an adjuvant in minor urinary
complaints.
The product is a traditional herbal medicinal
product for use in the specified indications
exclusively based upon long-standing use.
4.2. Posology and method of administration 4
Well-established use Traditional use
Posology Posology
Adolescents, adults and elderly
Indications 1), 2) and 3)
a) Comminuted herbal substance for
decoction: single dose of 1-5 g in 150 ml of
water, 2-3 times daily
b) Expressed juice (DER 1:1) from fresh root
subjected to a steam of ethanol: single dose
5 ml, diluted in small volume of water, 3
times daily
Indication 1) and 3)
c) Juice from fresh root: single dose 4-8 ml, 3
times daily
4
For guidance on herbal substance/herbal preparation administered as herbal tea or as infusion/decoction/macerate
preparation, please refer to the HMPC ‘Glossary on herbal teas’ (EMA/HMPC/5829/2010 Rev.1).
European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix
EMA/HMPC/475726/2020 Page 4/8
Well-established use Traditional use
d) Liquid extract (DER 1:1), extraction solvent
ethanol 30% V/V: single dose 2-8 ml, 3
times daily
e) Tincture (ratio of herbal substance to
extraction solvent 1:5), extraction solvent
ethanol 45% V/V: single dose 5-10 ml, 3
times daily
The use in children under 12 years of age is not
recommended (see section 4.4 ‘Special
warnings and precautions for use’).
Duration of use
If the symptoms persist longer than 2 weeks
during the use of the medicinal product, a
doctor or a qualified health care practitioner
should be consulted.
Method of administration
Oral use.
Indication 2)
Preparations are to be taken ½ hour before
meal.
Indication 3)
To ensure an increase of the amount of urine,
adequate fluid intake is required during
treatment (see section 4.4. Special warnings
and precautions for use).Kontext im Original-PDF öffnen ↗4.3 · Gegenanzeigen
Contraindications
4.3. Contraindications
Well-established use Traditional use
Hypersensitivity to the active substance or to
plants of the Asteraceae (Compositae) family.Original-PDF · Seite 5 ↗4.4 · Warnhinweise und Vorsichtsmaßnahmen
Special warnings and precautions for use
4.4. Special warnings and precautions for use
Well-established use Traditional use
Indication 1), 2) and 3)
Due to possible stimulation on bile secretion,
dandelion root is not recommended in case of
European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix
EMA/HMPC/475726/2020 Page 5/8
Well-established use Traditional use
obstruction of the bile duct, cholangitis, liver
disease, gallstones and any other biliary
diseases.
The use in children under 12 years of age has
not been established due to lack of adequate
data.
Indication 3)
If complaints or symptoms such as fever,
dysuria, spasms or blood in urine occur during
the use of the medicinal product, a doctor or a
qualified health care practitioner should be
consulted.
Because adequate fluid intake is required during
treatment (see section 4.2. Posology and
method of administration), dandelion root is not
recommended for patients with conditions
where reduced fluid intake is advised by a
medical doctor.
For preparations containing ethanol, the
appropriate labelling for ethanol, taken from the
‘Guideline on excipients in the label and
package leaflet of medicinal products for human
use’, must be included.Original-PDF · Seite 5–6 ↗4.5 · Wechselwirkungen
Interactions with other medicinal products and other forms of interaction
4.5. Interactions with other medicinal products and other forms of
interaction
Well-established use Traditional use
None reported.Original-PDF · Seite 6 ↗4.8 · Nebenwirkungen
Undesirable effects
4.8. Undesirable effects
Well-established use Traditional use
Allergic reactions may occur. The frequency is
not known.
If other adverse reactions not mentioned above
occur, a doctor or a qualified health care
practitioner should be consulted.Original-PDF · Seite 7 ↗Dokumentfassung nachweisen
SHA-256: 745b71ac0ec1d5ae5b13588d7def6f5f5be8b937391eb12831d818370e727b40
Der Hash kennzeichnet die abgerufene Datei. Die Dokumentfassung und der Bearbeitungsstatus des Pflanzenprofils sind getrennte Angaben.
Importstand: 27.10.2026 · Aktuelles EMA-Quellenprofil ↗
Dokumente beim Herausgeber · 8
Originaltitel bleiben erhalten. Entwürfe, ältere Fassungen und ergänzende Berichte können nebeneinander vorliegen; der Profilstatus bestimmt nicht die Gültigkeit jedes Dokuments.
- Call for scientific data for use in HMPC assessment work on Taraxacum officinale F.H. Wigg., radix
- Draft European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix - First version
- Final European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix
- Opinion of the HMPC on a European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix
- Draft list of references supporting the assessment of Taraxacum officinale F.H. Wigg., radix - First version
- Final list of references supporting the assessment of Taraxacum officinale F.H. Wigg., radix
- Draft Assessment report on Taraxacum officinale F.H. Wigg., radix - First version
- Final assessment report on Taraxacum officinale F.H. Wigg., radix
Dokumentenlinks geprüft: 27.10.2026
Quellenstand & Originalangaben
- Originalstatus
- R: Rapporteur assigned
- Zuletzt geändert laut EMA
- 21/06/2022
- Erstveröffentlichung laut EMA
- 30/03/2019
- Erfolgreicher Quellenabruf
- 27.10.2026